Need help? Text us and our team of experts will reply in minutes +00 00 00000

AOD-9604

CAS #: 386264-39-7

AOD-9604

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

AOD-9604 Overview

AOD-9604 is a synthetic peptide fragment derived from the C-terminus of the somatotropin sequence (fragment 176–191, with an added N-terminal Tyr). It is studied for its effects on lipolytic and anti-lipogenic pathways, β3-adrenergic signaling, and downstream pathway dynamics in laboratory and preclinical models.

Heffernan M. et al. (2001).

History

Developed in the late 1990s/early 2000s as a focused hGH fragment, AOD-9604 was advanced into early clinical programs to investigate mechanism-driven metabolic effects and safety. Subsequent summaries report randomized, placebo-controlled trials evaluating IGF-1, glucose tolerance, and immunogenicity endpoints in research settings.

Stier H. et al. (2013).

AOD-9604 Structure

CAS #: 386264-39-7

Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂

Molecular Weight: 1815.1 g/mol

PubChem ID: 71300630

Research Findings

AOD-9604 has been studied in signaling, structural, and systemic models, with research exploring its effects on lipid pathway dynamics, substrate utilization, and remodeling processes. Studies also highlight its potential influence on cartilage modeling, skeletal signaling, and pathway activity in preclinical settings.

Key Areas of Research::

  • Signaling: Lipid pathways, substrate dynamics

  • Structural: Cartilage, skeletal, connective matrix

  • Systemic: Remodeling, viability, signaling

Together, these findings suggest experimental potential for AOD-9604 across signaling, structural, and systemic pathways. By modulating lipid pathway dynamics and supporting matrix integrity, AOD-9604 provides a versatile platform for research into substrate characterization, structural modeling, and systemic resilience in laboratory settings.

Heffernan M. et al., 2001

Our Process

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our U.S. facility.
Text us, our dedicated team is here to help
Orders dispatched same-day from our U.S. facility.
Frequently Asked Questions

Orders dispatched same-day from our U.S. facility.

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.
In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Products from Raw Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.